| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,713 |
7,133 |
$407K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,456 |
7,855 |
$265K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,303 |
2,076 |
$164K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,272 |
3,103 |
$156K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,791 |
2,628 |
$97K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,411 |
2,206 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,877 |
2,336 |
$53K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,217 |
2,024 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
360 |
328 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
151 |
123 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
133 |
113 |
$4K |
| 99000 |
|
679 |
611 |
$980.12 |
| 81003 |
|
409 |
372 |
$755.30 |
| 87807 |
|
25 |
22 |
$159.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$27.88 |